KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Total Non-Current Liabilities: 2009-2024

Historic Total Non-Current Liabilities for Dynavax Technologies (DVAX) over the last 16 years, with Dec 2024 value amounting to $389.2 million.

  • Dynavax Technologies' Total Non-Current Liabilities rose 8.30% to $412.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $412.1 million, marking a year-over-year increase of 8.30%. This contributed to the annual value of $389.2 million for FY2024, which is 3.80% up from last year.
  • According to the latest figures from FY2024, Dynavax Technologies' Total Non-Current Liabilities is $389.2 million, which was up 3.80% from $374.9 million recorded in FY2023.
  • Dynavax Technologies' Total Non-Current Liabilities' 5-year high stood at $811.2 million during FY2021, with a 5-year trough of $292.0 million in FY2020.
  • Its 3-year average for Total Non-Current Liabilities is $389.5 million, with a median of $389.2 million in 2024.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first skyrocketed by 177.80% in 2021, then tumbled by 50.14% in 2022.
  • Dynavax Technologies' Total Non-Current Liabilities (Yearly) stood at $292.0 million in 2020, then skyrocketed by 177.80% to $811.2 million in 2021, then tumbled by 50.14% to $404.5 million in 2022, then dropped by 7.29% to $374.9 million in 2023, then climbed by 3.80% to $389.2 million in 2024.